Lorlatinib for the Treatment of Inflammatory Myofibroblastic Tumor after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report

Author:

Yagi Toshinari1,Kukita Yoji2,Matsuoka Haruki3,Wakamatsu Toru3,Tamiya Hironari3,Watanabe Makiyo3,Kakunaga Shigeki3,Takenaka Satoshi3,Kubo Chiaki4,Hashii Yoshiko5,Nakanishi Katsuyuki6

Affiliation:

1. Department of Outpatient Chemotherapy, Osaka International Cancer Institute, Japan

2. Laboratory of Genomic Pathology, Osaka International Cancer Institute, Japan

3. Department of Orthopedic Surgery, Osaka International Cancer Institute, Japan

4. Department of Pathology, Osaka International Cancer Institute, Japan

5. Department of Pediatrics, Osaka International Cancer Institute, Japan

6. Department of Diagnostic and Interventional Radiology, Osaka International Cancer Institute, Japan

Publisher

Japanese Society of Internal Medicine

Reference22 articles.

1. 1. Yamamoto H. Inflammatory Myofibroblastic Tumor. In: WHO Classification of Tumours. Soft Tissue and Bone Tumours. 5th ed. The WHO Classification of Tumours Editorial Board, Ed. IARC Press, Lyon, 2020: 109-111.

2. 2. In: Enzinger & Weiss's Soft Tissue Tumors. 7th ed. Goldblum JR, Folpe AL, Weiss SW, Eds. Inflammatory Myofibroblastic Tumor. Elsevier Inc., Philadelphia, 2020: 322-330.

3. 3. Fukano R, Matsubara T, Inoue T, Gondo T, Ichiyama T, Furukawa S. Time lag between the increase of IL-6 with fever and NF-kappaB activation in the peripheral blood in inflammatory myofibroblastic tumor. Cytokine 44: 293-297, 2008.

4. 4. Azuno Y, Yaga K, Suehiro Y, Ariyama S, Oga A. Inflammatory myoblastic tumor of the uterus and interleukin-6. Am J Obstet Gynecol 189: 890-891, 2003.

5. 5. Fujino H, Park YD, Uemura S, et al. An endobronchial inflammatory myofibroblastic tumor in a 10-yr-old child after allogeneic hematopoietic cell transplantation. Pediatr Transplant 18: E165-E168, 2014.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3